Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. Blood Adv 2019 12 10;3(23):3945-3950

Date

12/04/2019

Pubmed ID

31794603

Pubmed Central ID

PMC6963245

DOI

10.1182/bloodadvances.2019000931

Scopus ID

2-s2.0-85076339236   8 Citations

Abstract

The American Society of Hematology (ASH) convened 5 guideline panels to develop clinical practice recommendations addressing 5 management areas of highest importance to individuals living with sickle cell disease: pain, cerebrovascular complications, pulmonary and kidney complications, transfusion, and hematopoietic stem cell transplant. Panels were multidisciplinary and consisted of patient representatives, content experts, and methodologists. The Mayo Clinic Evidence-Based Practice Center conducted systematic reviews based on a priori selected questions. In this exposition, we describe the process used by ASH, including the GRADE approach (Grades of Recommendations, Assessment, Development and Evaluation) for rating certainty of the evidence and the GRADE Evidence to Decision Framework. We also describe several unique challenges faced by the guideline panels and the specific innovations and solutions used to address them, including a curriculum to train patients to engage in guideline development, dealing with the opioid crisis, and working with indirect and noncomparative evidence.

Author List

Murad MH, Liem RI, Lang ES, Akl EA, Meerpohl JJ, DeBaun MR, Tisdale JF, Brandow AM, Lanzkron SM, Chou ST, Webb S, Mustafa RA

Author

Amanda Brandow DO Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Hematology
History, 21st Century
Humans
United States